| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JOG.13438 |
| P698 | PubMed publication ID | 28714288 |
| P50 | author | Ho-Hsiung Lin | Q56642433 |
| P2093 | author name string | Sheng-Mou Hsiao | |
| Ko-Hsin Tsai | |||
| P2860 | cites work | The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society | Q28202868 |
| Muscarinic receptor antagonists for overactive bladder | Q34699525 | ||
| The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society | Q35057109 | ||
| Impact of Dry Mouth on Fluid Intake and Overactive Bladder Symptoms in Women taking Fesoterodine | Q36963197 | ||
| Effect of fluid management on fluid intake and urge incontinence in a trial for overactive bladder in women. | Q37045157 | ||
| An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction | Q37638442 | ||
| Current pharmacotherapy of nocturia | Q38095986 | ||
| Multiple dose pharmacokinetics of a new once daily extended release tolterodine formulation versus immediate release tolterodine | Q43591040 | ||
| Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial | Q45329229 | ||
| Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study | Q46660046 | ||
| Desmopressin orally disintegrating tablet effectively reduces nocturia: results of a randomized, double-blind, placebo-controlled trial | Q48252319 | ||
| Nocturia: a risk factor for falls in the elderly | Q50541957 | ||
| Autonomic dysfunction and arterial stiffness in female overactive bladder patients and antimuscarinics related effects. | Q51127982 | ||
| Comparisons of urodynamic effects, therapeutic efficacy and safety of solifenacin versus tolterodine for female overactive bladder syndrome. | Q51474348 | ||
| How should patients with an overactive bladder manipulate their fluid intake? | Q53157640 | ||
| Good urodynamic practices: uroflowmetry, filling cystometry, and pressure-flow studies. | Q53315918 | ||
| P433 | issue | 11 | |
| P921 | main subject | nocturia | Q1426443 |
| P304 | page(s) | 1719-1725 | |
| P577 | publication date | 2017-07-16 | |
| P1433 | published in | Journal of Obstetrics and Gynaecology Research | Q15767555 |
| P1476 | title | Tolterodine treatment of women with overactive bladder syndrome: Comparison of night-time and daytime dosing for nocturia | |
| P478 | volume | 43 |
| Q90206276 | Changing the Timing of Enzalutamide Intake from Morning to before Sleep at Night Overcame Enzalutamide-Induced Dysgeusia | cites work | P2860 |
Search more.